Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Uptake and excretion dynamics of gold nanoparticles in cancer cells and fibroblasts.

Ivošev V, Sánchez GJ, Stefancikova L, Haidar DA, González Vargas CR, Yang X, Bazzi R, Porcel E, Roux S, Lacombe S.

Nanotechnology. 2020 Mar 27;31(13):135102. doi: 10.1088/1361-6528/ab5d82. Epub 2019 Nov 29.

PMID:
31783387
2.

Fluorescent Radiosensitizing Gold Nanoparticles.

Jiménez Sánchez G, Maury P, Stefancikova L, Campion O, Laurent G, Chateau A, Bouraleh Hoch F, Boschetti F, Denat F, Pinel S, Devy J, Porcel E, Lacombe S, Bazzi R, Roux S.

Int J Mol Sci. 2019 Sep 18;20(18). pii: E4618. doi: 10.3390/ijms20184618.

3.

Quality control of gold nanoparticles as pharmaceutical ingredients.

Pallotta A, Boudier A, Creusot B, Brun E, Sicard-Roselli C, Bazzi R, Roux S, Clarot I.

Int J Pharm. 2019 Oct 5;569:118583. doi: 10.1016/j.ijpharm.2019.118583. Epub 2019 Jul 31.

PMID:
31376468
4.

The contribution of hydrogen peroxide to the radiosensitizing effect of gold nanoparticles.

Khalil TT, Bazzi R, Roux S, Fromm M.

Colloids Surf B Biointerfaces. 2019 Mar 1;175:606-613. doi: 10.1016/j.colsurfb.2018.12.041. Epub 2018 Dec 17.

PMID:
30580151
5.

Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy.

Butterworth KT, Nicol JR, Ghita M, Rosa S, Chaudhary P, McGarry CK, McCarthy HO, Jimenez-Sanchez G, Bazzi R, Roux S, Tillement O, Coulter JA, Prise KM.

Nanomedicine (Lond). 2016 Aug;11(16):2035-47. doi: 10.2217/nnm-2016-0062. Epub 2016 Jul 27.

6.

Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization.

Laurent G, Bernhard C, Dufort S, Jiménez Sánchez G, Bazzi R, Boschetti F, Moreau M, Vu TH, Collin B, Oudot A, Herath N, Requardt H, Laurent S, Vander Elst L, Muller R, Dutreix M, Meyer M, Brunotte F, Perriat P, Lux F, Tillement O, Le Duc G, Denat F, Roux S.

Nanoscale. 2016 Jun 9;8(23):12054-65. doi: 10.1039/c6nr01228k.

PMID:
27244570
7.

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging.

Tsoukalas C, Laurent G, Jiménez Sánchez G, Tsotakos T, Bazzi R, Stellas D, Anagnostopoulos C, Moulopoulos L, Koutoulidis V, Paravatou-Petsotas M, Xanthopoulos S, Roux S, Bouziotis P.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A89. doi: 10.1186/2197-7364-2-S1-A89. No abstract available.

8.

Enhanced chemiluminescence-based detection on gold substrate after electrografting of diazonium precursor-coated gold nanoparticles.

Houmed Adabo A, Zeggari R, Mohamed Saïd N, Bazzi R, Elie-Caille C, Marquette C, Martini M, Tillement O, Perriat P, Chaix C, Boireau W, Roux S.

J Colloid Interface Sci. 2016 Apr 1;467:271-279. doi: 10.1016/j.jcis.2016.01.030. Epub 2016 Jan 15.

PMID:
26803605
9.

Thermodynamic stability and kinetic inertness of a Gd-DTPA bisamide complex grafted onto gold nanoparticles.

Mogilireddy V, Déchamps-Olivier I, Alric C, Laurent G, Laurent S, Vander Elst L, Muller R, Bazzi R, Roux S, Tillement O, Chuburu F.

Contrast Media Mol Imaging. 2015 May-Jun;10(3):179-87. doi: 10.1002/cmmi.1616. Epub 2014 Aug 8.

PMID:
25130910
10.

Biodegradation mechanisms of iron oxide monocrystalline nanoflowers and tunable shield effect of gold coating.

Javed Y, Lartigue L, Hugounenq P, Vuong QL, Gossuin Y, Bazzi R, Wilhelm C, Ricolleau C, Gazeau F, Alloyeau D.

Small. 2014 Aug 27;10(16):3325-37. doi: 10.1002/smll.201400281. Epub 2014 May 3.

PMID:
24797733
11.

The In Vivo Radiosensitizing Effect of Gold Nanoparticles Based MRI Contrast Agents.

Miladi I, Alric C, Dufort S, Mowat P, Dutour A, Mandon C, Laurent G, Bräuer-Krisch E, Herath N, Coll JL, Dutreix M, Lux F, Bazzi R, Billotey C, Janier M, Perriat P, Le Duc G, Roux S, Tillement O.

Small. 2014 Feb 4. doi: 10.1002/smll.201302303. [Epub ahead of print]

PMID:
24677791
12.

The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents.

Miladi I, Alric C, Dufort S, Mowat P, Dutour A, Mandon C, Laurent G, Bräuer-Krisch E, Herath N, Coll JL, Dutreix M, Lux F, Bazzi R, Billotey C, Janier M, Perriat P, Le Duc G, Roux S, Tillement O.

Small. 2014 Mar 26;10(6):1116-24. doi: 10.1002/smll.201470036.

PMID:
24659273
13.

The biodistribution of gold nanoparticles designed for renal clearance.

Alric C, Miladi I, Kryza D, Taleb J, Lux F, Bazzi R, Billotey C, Janier M, Perriat P, Roux S, Tillement O.

Nanoscale. 2013 Jul 7;5(13):5930-9. doi: 10.1039/c3nr00012e. Epub 2013 May 24.

PMID:
23702968
14.

Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents.

Lartigue L, Hugounenq P, Alloyeau D, Clarke SP, Lévy M, Bacri JC, Bazzi R, Brougham DF, Wilhelm C, Gazeau F.

ACS Nano. 2012 Dec 21;6(12):10935-49. doi: 10.1021/nn304477s. Epub 2012 Nov 29.

PMID:
23167525
15.

Fused mesoionic heterocyclic compounds are a new class of aryl hydrocarbon receptor (AhR) agonist of exceptional potency.

Wall RJ, Bell DR, Bazzi R, Fernandes A, Rose M, Rowlands JC, Mellor IR.

Toxicology. 2012 Dec 16;302(2-3):140-5. doi: 10.1016/j.tox.2012.09.003. Epub 2012 Sep 20.

PMID:
23000282
16.

Automated oligonucleotide solid-phase synthesis on nanosized silica particles using nano-on-micro assembled particle supports.

Farre C, Lansalot M, Bazzi R, Roux S, Marquette CA, Catanante G, Blum LJ, Charvet N, Louis C, Chaix C.

Langmuir. 2010 Apr 6;26(7):4941-50. doi: 10.1021/la903572q.

PMID:
20000593
17.

Multistep continuous-flow microsynthesis of magnetic and fluorescent gamma-Fe2O3@SiO2 core/shell nanoparticles.

Abou-Hassan A, Bazzi R, Cabuil V.

Angew Chem Int Ed Engl. 2009;48(39):7180-3. doi: 10.1002/anie.200902181. No abstract available.

PMID:
19708045
18.

2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.

Bazzi R, Bradshaw TD, Rowlands JC, Stevens MF, Bell DR.

Toxicol Appl Pharmacol. 2009 May 15;237(1):102-10. doi: 10.1016/j.taap.2009.02.015. Epub 2009 Mar 2.

PMID:
19265716
19.

Optimization of the synthesis of nanostructured Tb3+-doped Gd2O3 by in-situ luminescence following up.

Ou M, Mutelet B, Martini M, Bazzi R, Roux S, Ledoux G, Tillement O, Perriat P.

J Colloid Interface Sci. 2009 May 15;333(2):684-9. doi: 10.1016/j.jcis.2009.01.062. Epub 2009 Jan 31.

PMID:
19251266
20.

Functionalization of luminescent aminated particles for facile bioconjugation.

Faure AC, Hoffmann C, Bazzi R, Goubard F, Pauthe E, Marquette CA, Blum LJ, Perriat P, Roux S, Tillement O.

ACS Nano. 2008 Nov 25;2(11):2273-82. doi: 10.1021/nn8004476.

PMID:
19206393
21.

Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).

Aiello S, Wells G, Stone EL, Kadri H, Bazzi R, Bell DR, Stevens MF, Matthews CS, Bradshaw TD, Westwell AD.

J Med Chem. 2008 Aug 28;51(16):5135-9. doi: 10.1021/jm800418z. Epub 2008 Jul 31.

PMID:
18666770
22.

Relationship between aryl hydrocarbon receptor-affinity and the induction of EROD activity by 2,3,7,8-tetrachlorinated phenothiazine and derivatives.

Fried KW, Bazzi R, Levy Lopez W, Corsten C, Schramm KW, Bell DR, Rozman KK.

Toxicol Appl Pharmacol. 2007 Oct 15;224(2):147-55. Epub 2007 Jul 19.

PMID:
17761204
23.

Misdiagnosis of atrial fibrillation and its clinical consequences.

Bogun F, Anh D, Kalahasty G, Wissner E, Bou Serhal C, Bazzi R, Weaver WD, Schuger C.

Am J Med. 2004 Nov 1;117(9):636-42.

PMID:
15501200
24.

Synthesis and properties of europium-based phosphors on the nanometer scale: Eu2O3, Gd2O3:Eu, and Y2O3:Eu.

Bazzi R, Flores MA, Louis C, Lebbou K, Zhang W, Dujardin C, Roux S, Mercier B, Ledoux G, Bernstein E, Perriat P, Tillement O.

J Colloid Interface Sci. 2004 May 1;273(1):191-7.

PMID:
15051451
25.

N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.

Darwiche N, Hatoum A, Dbaibo G, Kadara H, Nasr R, Abou-Lteif G, Bazzi R, Hermine O, de Thé H, Bazarbachi A.

Leukemia. 2004 Mar;18(3):607-15.

PMID:
14712289
26.

Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure.

Artinian NT, Harden JK, Kronenberg MW, Vander Wal JS, Daher E, Stephens Q, Bazzi RI.

Heart Lung. 2003 Jul-Aug;32(4):226-33.

PMID:
12891162
27.

Supplemental Content

Support Center